Organon (OGN) Debt Ratio (2020 - 2026)
Organon (OGN) posted quarterly Debt Ratio of 0.65 for Q2 2026, down 1.92% year-over-year from 0.67 in Q2 2025, and down 0.9% on a QoQ basis from 0.66 in Q1 2026.
Organon (OGN) Debt Ratio (2020 - 2026) Analysis & Trends
Organon has reported Debt Ratio for 7 years, with the latest figure at 0.65 in Q2 2026.
- Debt Ratio for Q2 2026 came in at 0.65, down 1.92% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.65 (down 1.92% YoY), and the FY2025 annual result was 0.67, down 0.93% from the prior year.
- Debt Ratio retreated to 0.65 in Q2 2026, from 0.66 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.86 in Q1 2022 and troughed at 0.65 in Q2 2026.
- A 5-year average of 0.74 and a median of 0.72 in 2024 frame the typical range for Debt Ratio.
- The widest annual swing landed in 2022, when Debt Ratio surged 445.27%; it then declined 12.68% in 2024.
- A 5-year view of Debt Ratio shows it stood at 0.81 in 2022, then dropped by 10.79% to 0.73 in 2023, then retreated by 6.49% to 0.68 in 2024, then retreated by 0.93% to 0.67 in 2025, then declined by 2.73% to 0.65 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.65 in Q2 2026, 0.66 in Q1 2026, and 0.67 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -0.31 |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.65 |
| Mar 31, 2026 | 0.66 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 0.65 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.68 |
| Dec 31, 2024 | 0.68 |
| Sep 30, 2024 | 0.69 |
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 0.73 |
| Dec 31, 2023 | 0.73 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.80 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.81 |
| Sep 30, 2022 | 0.83 |
| Jun 30, 2022 | 0.84 |
| Mar 31, 2022 | 0.86 |
| Dec 31, 2021 | 0.86 |
| Sep 30, 2021 | 0.82 |